108 — SR Medical Technology Income Statement
0.000.00%
Last trade - 00:00- HK$9.17bn
- HK$12.08bn
- HK$327.91m
Annual income statement for SR Medical Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 331 | 352 | 353 | 310 | 328 |
| Cost of Revenue | |||||
| Gross Profit | 318 | 346 | 352 | 309 | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 90.1 | 550 | 293 | 1,153 | 310 |
| Operating Profit | 241 | -198 | 59.2 | -843 | 17.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 133 | -334 | -69.9 | -968 | -136 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 76.2 | -320 | -129 | -919 | -110 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 208 | -320 | -129 | -919 | -110 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 209 | -320 | -129 | -919 | -110 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.023 | -0.101 | -0.046 | -0.287 | -0.034 |